Missing/wrong data?
Log in to edit
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
scientific article published on 01 May 2020
Author/s
author: Øystein Fluge, Knut Liestøl, Signe Spetalen, Harald Holte, Mats Jerkeman
Work details
Publication date
May 1, 2020
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.